Report summary
| Field | Value |
|---|---|
| Product | GLP-3 (RT) 30mg |
| Batch | RT30-2510-A |
| Sample name on the reports | Retatrutide 30mg |
| Reported purity | 99.650% (task #246859) |
| Measured content | 28.78 mg (label 30 mg, task #246859) |
| Identity | Identified as retatrutide in a blind GLP test (semaglutide / tirzepatide / retatrutide), task #246859 |
| Endotoxin | <1 EU/vial (task #246860, as reported) |
| Ordered / received / analyzed | Oct 24, 2026 / Nov 2, 2026 / Nov 3, 2026 (both reports) |
| Issuing laboratory | Janoshik Analytical (janoshik.com) |
| Laboratory verification | Task #246859 on Janoshik’s verification site · key 2XQ4ZSJQPCTUTask #246860 on Janoshik’s verification site · key 766ED2S6EKKR |
| Original reports | Purity, identity and content report (PDF) · Endotoxin report (PDF) |
Full test panel
| Test | Result | Note |
|---|---|---|
| Identity (blind GLP test) | Retatrutide | Task #246859; tested against semaglutide, tirzepatide, retatrutide |
| Purity | 99.650% | Task #246859, as reported |
| Content | 28.78 mg | Task #246859; label 30 mg |
| Endotoxin | <1 EU/vial | Task #246860, as reported (no limit stated on the report) |
Every row above is read from Janoshik Analytical tasks #246859 and #246860 for batch RT30-2510-A. Results apply to the samples the laboratory tested.
What these reports establish
The results above describe the samples of batch RT30-2510-A that Janoshik Analytical received on Nov 2, 2026 and analyzed on Nov 3, 2026: the blind test identified the sample as retatrutide, with 99.650% purity and 28.78 mg measured content against the 30 mg label, and the separate endotoxin report gives <1 EU/vial. The endotoxin report states the value without a limit. Neither report includes sterility testing, they do not describe other batches or strengths, and they do not establish any attribute they do not list. Confirm that the batch printed on a vial label matches RT30-2510-A before applying these records to it.
Common questions about these reports
- What does the 99.650% figure mean?
- It is the purity Janoshik Analytical reported for the sample of lot RT30-2510-A it received on Nov 2, 2026. It applies to that sample of this lot, not to other lots, and it is not a weight figure.
- Why does it say 28.78 mg on a 30 mg vial?
- 28.78 mg is the content the laboratory measured in the vial it tested; the label states 30 mg. The report states the measured amount; it does not round it to the label.
- How was identity checked?
- The test ordered was Janoshik's common GLP peptide blind test, which checks a sample against semaglutide, tirzepatide and retatrutide without being told which one to expect. The report identifies this sample as retatrutide (the compound sold here as GLP-3 (RT)).
- Is there an endotoxin result for this lot?
- Yes, in a separate Janoshik report (task #246860, analyzed Nov 3, 2026), which gives endotoxin <1 EU/vial for lot RT30-2510-A. That report states the value only; it does not state a limit, and neither report includes sterility testing.
- How do I know the reports are genuine?
- Open each report on Janoshik's own verification site (links below), or enter key 2XQ4ZSJQPCTU (task #246859) or 766ED2S6EKKR (task #246860) at janoshik.com/verify. The verification pages are hosted by the laboratory, not by this site.
- Do these reports apply to the vial I received?
- Only if the batch printed on your vial label is RT30-2510-A. A different batch has a different report; if your batch is not listed on this site, ask support with the batch number.
How to verify these documents
- Open each report on Janoshik’s verification site (task #246859, task #246860), or enter key
2XQ4ZSJQPCTUor766ED2S6EKKRat janoshik.com/verify. - Compare the sample, batch, dates and results with the reports on this page (PDF, PDF).
- Record the verification date next to the batch in the receiving log (how to verify a certificate).

